Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Exp Obstet Gynecol ; 43(2): 198-202, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27132409

RESUMO

BACKGROUND: Problems affecting the vaginal tract in diabetic women are very often neglected. The efficacy and safety of three gynecological treatments in diabetic women have been assessed. MATERIALS AND METHODS: A single-blind randomized progressive trial on 48 diabetic women affected by vaginal dryness, dyspareunia, and recurrent Candida infections was carried out. The ICIQ Vaginal Symptoms (ICIQ-VS) questionnaire was administered. RESULTS: The analysis of the parameters of ICIQ-VS questionnaire among the three groups showed significant difference only for "dragging pain" (p = 0.0 19) and "soreness" (p = 0.028). In all groups and for all parameters of the questionnaire, improvement of symptoms was observed. In particular, in Group 1 for all symptoms a highly significant difference was observed, to support the already known benefits of the products and of the proposed combination. Significant improvement was also observed in Group 2. CONCLUSIONS: The proposed treatment with DermoXEN® Ultracalming Special for diabetics and DermoXEN® Vitexyl vaginal gel exert effective moisturizing and soothing action. Indeed, the aforementioned products have been proven effective for the main gynecological problems of diabetic women.


Assuntos
Candidíase Vulvovaginal/prevenção & controle , Complicações do Diabetes/prevenção & controle , Diabetes Mellitus , Dispareunia/prevenção & controle , Glicerol/uso terapêutico , Ácido Hialurônico/uso terapêutico , Ácido Láctico/uso terapêutico , Ácido Pantotênico/análogos & derivados , Viscossuplementos/uso terapêutico , ortoaminobenzoatos/uso terapêutico , Administração Intravaginal , Adulto , Candidíase Vulvovaginal/tratamento farmacológico , Complicações do Diabetes/tratamento farmacológico , Combinação de Medicamentos , Dispareunia/tratamento farmacológico , Feminino , Humanos , Lipídeos/uso terapêutico , Pessoa de Meia-Idade , Ácido Pantotênico/uso terapêutico , Recidiva , Método Simples-Cego , Cremes, Espumas e Géis Vaginais/uso terapêutico , Vulvovaginite/tratamento farmacológico , Vulvovaginite/prevenção & controle
2.
Ceska Gynekol ; 70(5): 395-9, 2005 Sep.
Artigo em Tcheco | MEDLINE | ID: mdl-16180802

RESUMO

OBJECTIVE: a survey of effective natural compounds and probiotics with antifungal activity and their possible use in vulvovaginitis as a prophylactic or therapeutic drug. DESIGN: review of literature. SETTING: Charles University at Prague, Pharmaceutical Faculty at Hradec Kralove. METHODS: and review of literature and publications from medical data-bases. CONCLUSIONS: certain natural compounds were proved to exert antimycotic effects. The efficiency of garlic extract under in vitro conditions against yeast of C. albicans family becomes manifest within one hour. Essential oils present in the Cayenne pepper (Capsodum frutescens) exert considerable antifungal activity against C. albicans as well. Clove exerts lower antimycotic effects. The effects of Chinese leek are similar to garlic. Propolis also possesses antifungal properties, and sensitivity of the yeast strains decreases in the following order: C. albicans > C. tropicalis > C. crusei > C. guilliermondii. Its efficiency depends on the composition and place of origin. Tea trea oil (Melalauca alternifolia) is inhibiting strains of Candida family (genus) in minimal inhibiting concentration, higher concentrations are necessary for C. crusei and C. norvengensis. In the prophylaxis of vaginal candidoses, oral administration of the strains of Lactobacilus rhamnosus GR-1 and L. fermentum RC-14, B-54 may be recommended. Moreover there are suitable strains of L. brevis CD-2, L. salivarius FV-2, L. gasseri MB 335, L. plantarum, useful in the form of gel capsules (L. plantarum) or vaginal tablets (L. gasseri). The strains of L. acidophilus CRL 1294 and L. salivarius CRL 1328 display the capacity of self aggregation and co-aggregation with Candida. It should be pointed out that the probiotic strain of Lactobacillus (especially L. casei and L. rhamnosus) may, in exceptional cases, cause bacteriemia and sepsis, especially in immunodeficient patients and those who underwent surgery of alimentary tract. No protective effect against yeast infection was detected with vitamin E, any positive effect was not unequivocally confirmed with zinc, but adjusting zinc levels to normal may be recommended.


Assuntos
Antifúngicos/análise , Fitoterapia , Preparações de Plantas/química , Probióticos/análise , Vulvovaginite/prevenção & controle , Antifúngicos/uso terapêutico , Feminino , Humanos , Preparações de Plantas/uso terapêutico , Probióticos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA